Bleeding diathesis in amyloidosis with renal insufficiency associated with Crohn''s disease: response to desmopressin

A 53-yr-old man with a 33-yr history of Crohn's ileocolitis, complicated by arthritis and cologastric fistulization, was diagnosed with GI amyloidosis at the time of proctocolectomy. He had marked proteinuria (4.2 g/24 h) and moderate renal insufficiency (BUN of 35 mg/dl and serum creatinine of 2.5 mg/dl). During the operation, he had severe bleeding that required 11 U of blood. Postoperatively, desmopressin was administered, which resulted in a prompt cessation of bleeding. This case demonstrates the efficacy of desmopressin in reversing the bleeding diathesis in surgical patients with amyloidosis complicated by renal insufficiency.     

Multidrug resistance 1 gene expression in Indian patients with gastric carcinoma.

BACKGROUND: Gastric carcinoma is frequently refractory to chemotherapy. The multidrug resistance 1 gene (MDR1) encodes for a protein (p-glycoprotein) that functions as a drug efflux pump and thus contributes to resistance to chemotherapeutic agents. METHODS: We studied gastric tissues from 28 patients with gastric cancer for MDR1 expression, using immunohistochemistry. RESULTS: Sixteen (57%) of 28 cases showed MDR1 expression. Sections of normal mucosa away from the tumor showed perinuclear staining for MDR1 in surface epithelial cells, whereas tumor cells showed diffuse cytoplasmic positivity. CONCLUSIONS: Over one half of gastric carcinoma specimens at our center show MDR1 gene expression.     

Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model

RATIONALE: Priorities for developing improved regimens for treatment of latent tuberculosis (TB) infection include (1) developing shorter and/or more intermittently administered regimens that are easier to supervise and (2) developing and evaluating regimens that are active against multidrug-resistant organisms. OBJECTIVES AND METHODS: By using a previously validated murine model that involves immunizing mice with Mycobacterium bovis bacillus Calmette-Guérin to augment host immunity before infection with virulent Mycobacterium tuberculosis, we evaluated new treatment regimens including rifapentine and moxifloxacin, and assessed the potential of the Mycobacterium leprae heat shock protein-65 DNA vaccine to augment the activity of moxifloxacin. MEASUREMENTS: Quantitative spleen colony-forming unit counts, and the proportion of mice with culture-positive relapse after treatment, were determined. MAIN RESULTS: Three-month, once-weekly regimens of rifapentine combined with either isoniazid or moxifloxacin were as active as daily isoniazid for 6-9 mo. Six-month daily combinations of moxifloxacin with pyrazinamide, ethionamide, or ethambutol were more active than pyrazinamide plus ethambutol, a regimen recommended for latent TB infection after exposure to multidrug-resistant TB. The combination of moxifloxacin with the experimental nitroimidazopyran PA-824 was especially active. Finally, the heat shock protein-65 DNA vaccine had no effect on colony-forming unit counts when given alone, but augmented the bactericidal activity of moxifloxacin. CONCLUSIONS: Together, these findings suggest that rifapentine, moxifloxacin, and, perhaps, therapeutic DNA vaccination have the potential to improve on the current treatment of latent TB infection.     

Detection of new amino acid markers of liver trauma by proton nuclear magnetic resonance spectroscopy.

OBJECTIVE: We examined serum in patients of liver injury to explore the possible clinical application of abnormal micrometabolites as a marker of liver injury and severity in cases of traumatic liver damage. METHODS: Serum were screened by proton nuclear magnetic resonance spectroscopy in 96 patients with varying degree of liver injury and compared with concentrations in healthy control volunteers. RESULTS: Large quantities of phenylalanine and tyrosine were detected by spectroscopic analysis in patients with liver injury but not in those without liver injury (P < 0.001). Proton nuclear magnetic resonance spectroscopy revealed two unique amino acids, phenylalanine and tyrosine, in the sera of the subjects with liver injury, irrespective of the extent and type of injury gauged by radiology or laparotomy. Phenylalanine spectrum was obtained in all 84 patients with liver injury (100% sensitivity) whereas tyrosine spectrum was present in 83 out of 84 patients (98.8% sensitivity) suggesting that these amino acids were specifically released in the patients of liver injury. Significant correlations were observed between phenylalanine and tyrosine concentrations and total bilirubin levels and albumin levels. Serum phenylalanine and tyrosine concentrations correlated well with imaging and laparotomy findings of liver injury. CONCLUSION: Phenylanaline and tyrosine appear to be specific and new markers of liver injury.     

Brief communication: CAPriCORN: Chicago Area Patient-Centered Outcomes Research Network

The Chicago Area Patient-Centered Outcomes Research Network (CAPriCORN) represents an unprecedented collaboration across diverse healthcare institutions including private, county, and state hospitals and health systems, a consortium of Federally Qualified Health Centers, and two Department of Veterans Affairs hospitals. CAPriCORN builds on the strengths of our institutions to develop a cross-cutting infrastructure for sustainable and patient-centered comparative effectiveness research in Chicago. Unique aspects include collaboration with the University HealthSystem Consortium to aggregate data across sites, a centralized communication center to integrate patient recruitment with the data infrastructure, and a centralized institutional review board to ensure a strong and efficient human subject protection program. With coordination by the Chicago Community Trust and the Illinois Medical District Commission, CAPriCORN will model how healthcare institutions can overcome barriers of data integration, marketplace competition, and care fragmentation to develop, test, and implement strategies to improve care for diverse populations and reduce health disparities.     

Crescent posterior fossa durotomy for occipito-marginal venous sinus preservation: A pilot study

Purpose

The standard approach of midline suboccipital craniectomy entails sacrifice of the Occipito—marginal sinus. We have attempted to preserve this venous channel by using a durotomy technique which preserves this system. In a pilot study initiative, two groups of patients using this technique versus the standard approach, were compared in terms of per and post operative benefits, morbidity and complications. The literature with reference to the anatomy and venous flow dynamics of the occipital and marginal sinuses and their significance has been reviewed. Similarly, literature regarding dural closure technique with reference to postoperative complications has also been reviewed.

Methods

In this novel approach, the dura is opened as a crescent to avoid damage to the occipital sinus. This technique was compared with the standard midline dural opening technique by random usage of both techniques in 24 patients.

Results

The ‘crescent’ approach has been found to reduce the need for duroplasty, with comfortable primary closure and to reduce the risk of postoperative pseudomeningocele.

Conclusions

This is a novel dural opening technique which attempts to preserve the normal venous flow physiology. In essence it helps in increased primary dural closures and reduction of Pseudomeningiocele/CSF leak as well as blood loss and venous hypertension.     

An unusual presentation of primary pelvic hydatid cyst

Aim-Background

Human echinococcosis is a zoonotic infection. Musculoskeletal involvement presents in just 1–4% of cases. Primary pelvic hydatid cyst is a rare entity.

Method

We report the case of an unusual presentation of primary pelvic hydatid cyst in a 38-year-old male.

Results

The patient presented to our hospital complaining of a pain in the lower abdomen for the past month and difficulty in passing urine for a week. MRI of pelvis and both hips showed a multiloculated cystic lesion in the pelvis that suggested a hydatid cyst with daughter cyst, 9.4 × 6.7 cm, with bony and soft tissue involvement. The patient underwent a cystopericycstectomy, which revealed an infected hydatid cyst in the rectovesical pouch; excision of the cyst was performed.

Conclusion

Primary pelvic hydatid cyst is a rare entity. Surgery is recommended to remove macroscopic cystic lesions and protect functions.